Anixa Biosciences Analyst Ratings
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)
Anixa Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
Buy Rating for Anixa Biosciences Backed by Strong Patent Position and Promising CAR-T Therapy Trial Results
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and Amylyx Pharmaceuticals Inc (AMLX)
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
Anixa Biosciences (ANIX) Receives a Buy From H.C. Wainwright
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX), Roche Holding AG (OtherRHHVF) and Bristol-Myers Squibb (BMY)
H.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Anixa Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
No Data